FDA Adverse Event Injury Summary report: N

LIFECOICE

MDR report key: 3142473 · Received March 30, 2013

Report

Report Number
3008185181-2013-00001
Event Type
Injury
Date Received
March 30, 2013
Date of Event
February 28, 2013
Report Date
February 28, 2013
Manufacturer
INOVA LABS
Product Code
CAW
PMA / PMN Number
K072688
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
WA, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

OTHER SERIOUS (IMPORTANT MEDICAL EVENTS) SELECTED BECAUSE IT WAS ALLEGED BY THE PT THAT PRODUCT CAUSED STROKE. BASED UPON CONSERVATIVE MEASURES WE ARE REPORTING AN ALLEGED ADVERSE EVENT BECAUSE IT CANNOT BE DETERMINED WITH 100 PERCENT CERTAINTY THAT THE INOVA LABS DEVICE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. A PRODUCT PROBLEM IS BEING REPORTED BECAUSE BASED UPON THE ALLEGED ADVERSE EVENT IF IT OCCURS AGAIN IT IS PROBABLE THAT IT COULD CAUSE SEVERE INJURY. IN SUBSEQUENT COMMUNICATION THE PT INDICATED THAT THE ALLEGED STROKE LIKELY OCCURRED IN (B)(6) FOLLOWING HIS RETURN FROM (B)(6). THIS CONTRADICTS THE ORIGINAL COMPLAINT STATEMENT. DURING A SUBSEQUENT MEETING BETWEEN AN INOVA LABS REPRESENTATIVE, THE PT, AND THE PT'S WIFE, THEY REITERATED THAT THE STROKE MOST LIKELY IS A SECONDARY SYMPTOMS OF A CARDIAC ABNORMALITY. THE LIFECHOICE PRODUCT IS A PULSE-MODE DEVICE.

Description of Event or Problem · 1

PT REPORTED THAT LIFECHOICE FAILED ON A FLIGHT FROM (B)(6) TO (B)(6) AND THAT PT'S OXYGEN SATURATION DROPPED TO 64%. PATIENT STATED THAT HE SUSPECTS LIFECHOICE CAUSED STROKE DURING TRIP. PT STATED THAT A CEREBRAL INCIDENT WAS IDENTIFIED THROUGH TESTING. LOCATION AND DATE OF TESTING UNK. PT INDICATED HE WAS 43% LUNG CAPACITY. PT STATED THAT HIS DOCTOR PRESCRIBED CONTINUOUS FLOW THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
131226 LIFECOICE PORTABLE OXYGEN CONCENTRATOR CAW INOVA LABS XYC100 WO1049

Patients

Seq Age Sex Outcome Treatment
1 70 YR Other